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Abstract
Introduction: The nucleotide-binding oligomerization domain-like receptor (NLR) family has been recognized as
comprising intracellular pattern recognition receptors in which NLRP3 (NLR family, pyrin domain containing 3)
plays an important role in the initiation of host immune inflammatory responses. The genetic variants have been
recognized to be critical determinants of interindividual differences in both inflammatory responses and clinical
outcomes in critical illness. However, little is known about the clinical relevance of NLRP3 gene polymorphisms in
critical illness.
Methods: A total of 718 patients with major blunt trauma were included in this study. Six tag SNPs (tSNPs) were
selected from the entire NLRP3 gene through construction of haplotype bins, and they were genotyped using a
pyrosequencing method. They were analyzed in relation to sepsis morbidity rate, multiple organ dysfunction
(MOD) scores and IL-1b production. Moreover, the functionality of the rs2027432 polymorphism was assessed by
the observation of its effect on transcriptional activities.
Results: Among the six tSNPs genotyped in this study, two of them (rs2027432 and rs12048215) were significantly
associated with sepsis morbidity rate and MOD scores. A significant association was also observed between these
two polymorphisms and IL-1b production by peripheral leukocytes in response to ex vivo lipopolysaccharide
stimulation. However, no combined effects were found between these two polymorphisms. In addition, the
rs2027432 polymorphism could significantly enhance the promoter activities of the NLRP3 gene.
Conclusions: rs2027432 and rs12048215 polymorphisms might be used as relevant risk estimates for the
development of sepsis and MOD syndrome in patients with major trauma, in which rs2027432 might be a
functional SNP.
Introduction
Trauma is a major and costly public health problem
worldwide, ranking as the third-leading cause of death.
With great improvements in emergency care systems,
the majority of severe trauma patients, even if they sur-
vive injuries, have complications after admission, leading
to in-hospital death of trauma patients. Sepsis and
multiple organ dysfunction syndrome (MODS) have
been shown to be common and severe complications in
trauma patients [1]. Therefore, preventing sepsis and
MODS is crucial in the treatment of patients who sur-
vive major trauma. It has been demonstrated that inap-
propriate immune inflammatory response contributes to
the development of sepsis and MODS in major trauma
patients [2]. Increasing evidence suggests that genetic
variants, particularly SNPs, are critical determinants of
interindividual differences with regard to both inflam-
matory responses and clinical outcomes in trauma
patients [3,4]. Delineating the variation in genes and
associated differences in response to trauma might
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lored diagnostic and therapeutic interventions that will
improve outcomes in patients with major trauma.
The nucleotide-binding oligomerization domain-like
receptor (NLR) family has been recognized as compris-
ing intracellular pattern recognition receptors, which
play important roles in the initiation of host immune
inflammatory responses [5]. In humans, more than 20
NLRs have been identified, among which NLR family,
pyrin domain containing 3 (NLRP3), is the one most
often described. NLRP3 is expressed predominantly in
peripheral blood leukocytes [6]. In response to invading
pathogens, NLRP3 rapidly forms a cytoplasmic complex
with the adapter protein apoptosis-associated specklike
protein and the effector cysteine protease caspase 1, that
is, the NLRP3 inflammasome, which has been shown to
play a central role in the regulation of the maturation
and secretion of the proinflammatory cytokines IL-1b
and IL-18 [7,8]. The expression of NLRP3 has been
shown to be significantly upregulated in mouse macro-
phages [9] and human neutrophils [10] in response to
bacterial lipopolysaccharide (LPS) stimulation. The
defect of the NLRP3 gene results in the hyporesponsive-
ness or nonresponsiveness of C57BL/6 mouse strains to
LPS challenge, showing decreased levels of serum IL-1b
and IL-18 and lower mortality [9]. In addition, the
expression of the NLRP3 inflammasome mRNAs has
been shown to be well associated with the outcomes of
patients with sepsis [11].
Growing evidence suggests that genetic variants within
the NLRP3 gene might be an important determinant of
the magnitude of immune inflammatory responses,
influencing susceptibility to infectious and noninfectious
diseases [12]. Approximately 60 SNPs have been identi-
fied within the entire NLRP3 gene [13], among which
the most often described are rs10754558, rs12065526,
rs4612666, rs4925648, rs10925019, rs10925027,
rs3806265 and rs35829419. They have been shown to be
well associated with susceptibility to HIV infection [14],
type 1 diabetes [15], food-induced anaphylaxis [6], rheu-
matoid arthritis [16], celiac disease [15,17] and Crohn’s
disease [18], respectively. In spite of the above findings,
there are numerous inconsistencies concerning the clini-
cal relevance of these polymorphisms [19-21].
In this study, we hypothesized that the genetic varia-
tions in the NLRP3 g e n em i g h ta f f e c tt h em a g n i t u d eo f
immune inflammatory responses following trauma,
which subsequently determines the susceptibility to sep-
sis and MODS in patients with major trauma. To com-
prehensively assess the association of common genetic
variants within the entire NLRP3 gene with sepsis sus-
ceptibility, we selected a set of tag SNPs (tSNPs) within
the entire NLRP3 gene and investigated their clinical
relevance in relation to the development of sepsis and
MODS in patients with major trauma. Two of them
were found to be well associated with risk of sepsis and
MODS in patients with major trauma.
Materials and methods
Study population
A total of 718 unrelated patients with major trauma
(577 male and 141 female) were prospectively recruited
into this study. All of them are ethnic Han Chinese and
live in Chongqing city. All eligible patients were conse-
cutively admitted to the Department of Trauma Surgery
in the Daping Hospital and the Chongqing Emergency
Medical Center between 1 January 2005 and 1 June
2010. They were enrolled in the study if they met the
following entry criteria: (1) age between 18 and 65
years, (2) combined injury patients with expected Injury
Severity Score (ISS) > 16 and (3) probability of survival
> 48 hours. Patients were not eligible if they had pene-
trating injuries or preexisting cardiovascular, respiratory,
renal, hepatic, hematologic or immunological diseases.
ISS were calculated according to the 2005 abbreviated
injury scale developed by independent evaluators [22].
All patients requiring surgical intervention received
standard surgical care and postoperative ICU treatment.
The protocol of the study was approved by the Ethical
and Protocol Review Committee of the Third Military
Medical University, and informed consent was obtained
from the patients or their next of kin. Patient confiden-
tiality was preserved according to the guidelines for stu-
dies of human subjects.
Clinical evaluation
The patients with major trauma were prospectively
monitored after admission by physicians who did not
know the patients’ genotypes. A sepsis diagnosis was
made if patients met all of the following criteria: clinical
evidence of infection, body temperature > 38.5°C or <
36.5°C and leukocyte count > 10 × 10
9/L or < 4 × 10
9/
L. Infection was defined as a clinically obvious source or
positive bacterial cultures. Pneumonia was diagnosed
when a predominant organism was isolated from appro-
priately obtained sputum cultures in the setting of puru-
lent sputum production and/or a new or changing
pulmonary infiltrate on chest X-ray film. Bloodstream
infections were diagnosed on the basis of isolation of a
predominant organism from blood cultures obtained
under sterile conditions. The criteria for urinary tract
infections included > 10 white blood cells/high-power
field on microscopic examination, isolation of > 10
5
organisms/ml urine or > 10
4 organisms with symptoms.
The criteria for catheter-related infections included iso-
lation of > 15 colony-forming units from catheter tips
cultured only in the setting of suspected infection.
Wound infection was identified by drainage of purulent
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laboratory data were collected during the hospital stays,
and clinical events were recorded thereafter until
patients’ death or hospital discharge. MOD scores were
calculated as the sum of the simultaneously obtained
individual organ scores on each hospital day [23]. The
MOD scores and sepsis diagnoses were determined by
individuals who did not know the patients’ genotypes.
Selection of tSNPs and bioinformatics analysis
The full sequence of the human NLRP3 gene included 3
kb upstream of the transcription start site, all exons and
introns, and 2 kb downstream of the stop codon (37.953
kb total), which was pinpointed to chromosome 1, posi-
tions 247576458 to 247614410 [GenBank:114548].
Genetic variation data for the entire NLRP3 gene were
obtained from the HapMap project for the 45 unrelated
Chinese Han in Beijing (CHB) population http://www.
ncbi.nlm.nih.gov/projects/SNP/snp_viewTable.cgi?
pop_id=4440. In this database, 35 SNPs with a minor
allele frequency (MAF) ≥ 5% were identified, and we
partitioned them in “bins” inferred according to the r
2
linkage disequilibrium (LD) statistic (threshold ≥ 0.8)
[24]. A maximally informative tSNP was then selected
from each bin using TAGster [25]. This algorithm
selects a subset of tSNPs that capture all known com-
mon genetic variants within the entire gene. To deter-
mine the possible functionality of the tSNPs selected
from the 5’-flanking region of the NLRP3 gene, online
software was used to analyze the effect of these SNPs
(rs2027432 and rs3738448) on potential transcription
factor-binding sites [26].
Genotyping of tSNPs
Blood specimens were collected in tripotassium ethyle-
nediaminetetraacetic acid sterile tubes from trauma
patients immediately after their admission to avoid the
effect of blood transfusion. The genomic DNA was iso-
lated from whole blood using the Wizard Genomic
DNA Purification Kit (Promega, Madison, WI, USA)
according to the manufacturer’sp r o t o c o l .T h eD N A
concentration in all samples was determined by UV
spectrophotometry, adjusted to a concentration of 50
μg/ml with sterile distilled water and stored at -80°C.
Pyrosequencing was used for genotyping [27]. Genotyp-
ing was performed in a blinded fashion without knowl-
edge of the patients’ clinical data, and approximately
10% of the samples were genotyped in duplicate to
monitor genotyping quality.
Plasmid construction
The possible effect of rs2027432, which is located in the
5’-flanking region (-1,017 G/A), on the promoter activity
was investigated using a reporter gene assay system. In
brief, genomic DNA was obtained from patients homo-
zygous for the G allele at position -1,017. The primers
used were 5’-TCG ACG CGT CAA GCT ATC CTC
CCG CCT CT-3’ (forward) and 5’-CCG AAG CTT
CAA TCT CCC CCA CTG CTC TC-3’ (reverse). MluI
and HindIII restriction sites (underlined) were intro-
duced through PCRs. After being digested with restric-
tion enzymes MluIa n dHindIII, the PCR products of a
1,760-bp sequence (from about -1,661 to about +99)
[28] of the NLRP3 gene were inserted directly into a
promoterless pGL3-Basic vector (Promega) containing
the firefly luciferase gene as a reporter. The resulting
construct containing the -1,017 G was then used to gen-
erate the construct containing the -1,017 A using the
QuikChange Site-Directed Mutagenesis Kit (Agilent
Technologies, Inc, Santa Clara, CA, USA) according to
the standard protocol. The mutation primers used were
5’-CCA ACT GCT TAT TCT AGC TTC TCT GTG-3’
(forward) and 5’-TTC CGA TGA CTA CCA CCT TTC
TAC AGA-3’ (reverse). All constructs used in this study
were restriction-mapped and direct-sequenced (TaKaRa
Biotech, Dalian, China) to confirm their authenticity.
Reporter assay
Human U937 cells were cultured in RPMI 1640 medium
(HyClone/Thermo Fisher Scientific, Logan, UT, USA)
containing 10% FCS, 3 mM glutamine, penicillin-strep-
tomycin (100 U/ml for each) and 23 mM sodium bicar-
bonate at 37°C in a humidified 5% CO2 air atmosphere.
After incubation for 24 hours, the cultured cells were
cotransfected with 0.8 μg of the constructed vectors or
pGL3-Basic original plasmid and 20 ng of control
Renilla luciferase reporter plasmid pRL-CMV using the
Lipofectamine 2000 system (Invitrogen/Life Technolo-
gies, Carlsbad, CA, USA). At 24 hours posttransfection,
the cells were treated with LPS (100 ng/ml) for 24
hours, then the luciferase activity of the transfected cells
was measured using the Luciferase Assay System (Pro-
mega) following the supplier’s protocol on a Luminos-
kan Ascent microplate luminometer (Thermo Fisher
Scientific, Helsinki, Finland). Transfection efficiency was
normalized by measuring the luciferase activity of con-
trol plasmid pRL-CMV. Luminescence experiments
were performed in triplicate with each transfection.
Three independent transfections were performed for
each constructed vector. The results are expressed as
fold increases in relative luciferase activity of the NLRP3
promoter construct vectors compared with the relative
luciferase activity of pGL3-Basic.
Ex vivo LPS stimulation of whole blood
A human whole-blood assay was performed as described
previously [29]. In brief, aliquots of whole blood col-
lected from the trauma patients immediately after
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culture medium and incubated with 100 ng/ml LPS
(Escherichia coli O26:B6; Difco Laboratories/BD Micro-
biology Systems, Detroit, MI, USA) in a sample mixer at
37°C for 4 hours. The supernatants were carefully col-
lected after centrifugation and stored at -80°C for assays
of IL-1b production, which was determined by ELISA
according to the manufacturer’s instructions (R&D Sys-
tems, Minneapolis, MN, USA), the theoretical sensitivity
(as stated by the manufacturer) of the immunoassay was
2 pg/ml.
Statistical analysis
Sample size was calculated using the online Power and
Sample Size software program [30]. The desired power
of our study was set at 80% with a significance level of
0.05 calculated using a two-sided test. We chose the
log-additive inheritance model, which is the most suita-
ble one for polygenic diseases. On the basis of our cal-
c u l a t i o n su s i n gt h eP o w e ra n dS a m p l eS i z es o f t w a r e
program, our sample (N = 718) was considered adequate
to study the tSNPs of the NLRP3 gene.
Allele frequencies for each tSNP were determined by
gene counting. The genotype distribution of each tSNP
was analyzed for deviations from the Hardy-Weinberg
equilibrium using c
2 analyses. The extent of pairwise
LD (r
2-value) between polymorphisms was determined
using Haploview version 4.1 software. The association of
the NLRP3 gene polymorphisms with plasma IL-1b
levels was determined using one-way analysis of var-
iance. The association between polymorphisms and
MOD scores was assessed using analysis of covariance
testing with age, sex ratio and ISS to adjust for possible
confounding effects. Three genetic models were used
(allele-dose, dominant, and recessive). The association of
genotypes with sepsis morbidity rate was determined by
c
2 analysis. ORs with 95% confidence intervals were cal-
culated by using multivariate logistic regression models
to estimate the relative risk of sepsis. All P-values were
two-sided, and P < 0.05 after the Bonferroni correction
for multiple testing was defined as statistically signifi-
cant. All statistical analysis was carried out using the
SPSS version 11.5 statistical software package (SPSS,
Inc, Chicago, IL, USA).
Results
Construction of bins and selection of tSNPs
A total of 35 SNPs with a minor allele frequency ≥ 0.05
were shown within and around the NLRP3 gene from
the HapMap database for the CHB population. Five bins
were constructed among 23 SNPs based on the r
2 LD
statistic (threshold ≥ 0.8) (Figure 1A). One tSNP was
selected from each bin for genotyping (Figure 1B).
rs2027432, though it did not form any bin with other
SNPs, was located in the 5’-flanking region (-1,017 G/A)
and selected because of its potential effect on the bind-
ing of transcription factor M y o D .T h e r e f o r e ,s i xS N P s
(rs2027432, rs3738448, rs12048215, rs4612666,
rs1539019 and rs10754558) were selected from among
this study cohort. They were located in the 5’-flanking
region (rs2027432 and rs3738448), intron 3
(rs12048215), intron 7 (rs4612666), intron 8 (rs1539019)
and 3’-UTR (rs10754558), respectively (Figure 1C).
Allele frequencies and genotype distribution of the NLRP3
gene polymorphisms among trauma patients
The genotyping success rates of the six tSNPs by pyro-
sequencing ranged from 98.2% to 100% in our study
cohort. The MAFs among the 718 trauma patients were
5.5% (rs2027432), 19.2% (rs3738448), 26.0%
(rs12048215), 46.1% (rs4612666), 40.7% (rs1539019) and
40.8% (rs10754558), respectively, which were quite simi-
lar to those observed in the 45 unrelated CHB cohort in
the HapMap database. The genotype distribution of all
six tSNPs was in agreement with the Hardy-Weinberg
equilibrium (P > 0.05) (Table 1), indicating that the
allele and genotype frequencies of these tSNPs in the
population remain constant. That is to say, they are in
equilibrium from generation to generation.
Clinical association of NLRP3 gene polymorphisms with
development of sepsis and MODS in trauma patients
The patient cohort comprised a total of 718 consecutive
Han Chinese patients, 577 male and 144 female, with
mean ± SD age of 40.6 ± 13.8 years and a mean ± SD
ISS of 22.5 ± 10.0. The demographic and baseline char-
acteristics and the clinical data from 718 severe trauma
patients are summarized in Table 2. All patients sur-
vived ≥ 48 hours after admission. Two hundred eighty-
seven patients (40.0%) developed sepsis. Pathogens were
identified as causative microorganisms in the blood cul-
tures of 124 septic patients (43.2%). The common
pathogens identified in this study cohort were Staphylo-
coccus aureus, coagulase-negative staphylococci, Kleb-
siella pneumoniae, Acinetobacter baumanii,
Pseudomonas aeruginosa, Escherichia coli, Enterococcus
sp. and Enterobacter cloacae. Gram-negative infections
accounted for 17.1%, Gram-positive infections accounted
for 6.3% and mixed infections accounted for 11.1%,
respectively. The median time point for sepsis occur-
rence in the whole study cohort was 7 days (IQR 5.0 to
8.0 days). Organ dysfunction occurred in 299 patients
(41.6%), from among whom 84 (28.1%) had two or more
organ dysfunctions. Among the patients with MODS,
those with sepsis accounted for 70.2%. Among the
patients with sepsis, the median time point for MODS
occurrence was 8 days (IQR = 6.5 to 10.5 days). With
respect to the patients without sepsis, the median time
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days).
As shown in Table 3, there were no significant differ-
ences in age, sex ratio or ISS among patients stratified
according to the different genotypes of each tSNP. The
rs2027432 polymorphism, although it was found in only
three patients with variant homozygotes in this study
cohort, was significantly associated with higher risk of
MODS. It was associated with significantly higher MOD
scores in patients with the A variant allele than in
patients with the G allele (P = 0.024 in case of recessive
effect). The sepsis morbidity rate was also much higher
in patients with the A variant allele, with 66.7% in AA
and 43.8% in GA vs 39.3% in GG, although there was no
statistically significant difference between the different
genotypes. In addition, the rs12048215 polymorphism
Figure 1 Overview of selected tag SNPs within the entire NLRP3 gene. (A) The pairwise analysis of linkage disequilibrium (LD), based on r
2,
among the 35 SNPs with a minor allele frequency (MAF) ≥ 5% within the NLRP3 gene and the 5-kb up- and downstream regions. The selected
six tag SNPs (tSNPs) are indicated by trigones. A LD plot of the 35 SNPs in the 37.953-kb region is displayed by using an r
2 black-and-white color
scheme. Black represents very high LD correlation between SNPs (r
2 = 0.8 to 1), and white indicates the absence of correlation between SNPs (r
2
= 0 to 0.2). (B) The six tSNPs and SNPs that are indirectly measured by tSNPs are listed with corresponding r
2 values. Major and minor alleles of
the selected tSNPs are given with their frequencies, based on the HapMap data for the Chinese Han Beijing (CHB) population. (C) The exon-
intron structure of the NLRP3 gene and the locations of the tSNPs are shown. rs2027432 (-1,017 G/A) and rs3738448 (-23 G/T) map to within the
5’-flanking region. rs12048215 (5,134 A/G), rs4612666 (19,613 C/T) and rs1539019 (20,844 C/A) are located in introns 3, 7 and 8, and rs10754558
(32,579 C/G) is located in the 3’-untranslated region (3’-UTR).
Table 1 Distribution of the six tag SNPs of the NLRP3 gene among trauma patients
MAF (%) Genotypes, n (%)
SNPs Number of patients Patients Database* Wild type Heterozygous Variant HWE test
rs2027432 718 5.5 8.9 642 (89.4) 73 (10.2) 3 (0.4) 0.73
rs3738448 705 19.2 16.7 454 (64.4) 231 (32.8) 20 (2.8) 0.18
rs12048215 718 26.0 25.6 398 (55.4) 267 (37.2) 53 (7.4) 0.42
rs4612666 711 46.1 40 193 (27.1) 380 (53.5) 138 (19.4) 0.06
rs1539019 718 40.7 43.3 251 (35.0) 349 (48.6) 118 (16.4) 0.93
rs10754558 714 40.8 50 246 (34.5) 354 (49.6) 114 (15.9) 0.54
*Data are derived from the HapMap database for Chinese Han in Beijing (n = 45). HWE = Hardy-Weinberg equilibrium; MAF = minor allele frequency.
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rate, showing 26.4% in GG and 36.6% in AG vs 44% in
AA (P = 0.012 in case of dominant effect and P = 0.038
in case of recessive effect). Data from multiple logistic
regression analyses further indicated that the patients
with the rs12048215 polymorphism had a lower risk for
developing sepsis (OR = 0.692, 95% CI = 0.535 to 0.896;
P = 0.005) after adjusting for possible confounders,
including age, sex ratio and ISS. However, this poly-
morphism was not associated with MOD scores. There
were no significant associations with sepsis morbidity
rate and MOD scores for the other four SNPs
(rs3738448, rs4612666, rs1539019 and rs10754558). Con-
cerning the combined effect between the rs2027432 and
rs12048215 polymorphisms, no significant differences
were observed in sepsis morbidity rate (46.1% vs 41.1%; P
= 0.409) and MOD scores (4.3 ± 0.4 vs. 4.2 ± 0.1; P =
0.739) between patients with combined and single-variant
genotypes (AA-AA + GA-AA + GA-AG vs GG-AA +
GG-AG).
Association of rs2027432 and rs12048215 polymorphisms
with IL-1b production
NLRP3 is a key molecule for the maturation and secre-
tion of IL-1b [31]. Therefore, we hypothesized that the
rs2027432 and rs12048215 polymorphisms might be
associated with IL-1b production. Peripheral blood was
taken from patients immediately after admission in an
attempt to avoid the potential effects of nongenetic fac-
tors, and we stimulated the samples with LPS for IL-1b
production. As shown in Figure 2, these two poly-
morphisms were significantly associated with IL-1b pro-
duction. The rs2027432 polymorphism was significantly
associated with higher IL-1b production, with IL-1b
levels significantly higher in patients with the variant A
allele than in those with the wild-type G allele (P =
0.003 for dominant effect and P <0 . 0 0 0 1f o rr e c e s s i v e
effect). The rs12048215 polymorphism was significantly
associated with lower IL-1b production (P = 0.018 for
dominant effect and P = 0.00016 for recessive effect).
Data from linear regression analysis indicated that the
association of these two polymorphisms with IL-1b pro-
duction was significantly in allele-dose dependent (P <
0.0001 for rs2027432 and P = 0.001 for rs12048215).
With respect to their combined effect on IL-1b produc-
tion, no significant difference was observed between
patients with combined and single-variant genotypes
(AA-AA + GA-AA + GA-AG vs GG-AA + GG-AG)
(1,483.2 ± 889.2 pg/ml vs 1,238.2 ± 363.9 pg/ml; P =
0.343).
Effect of the rs2027432 polymorphism on promoter
activity
In view of the location of the rs2027432 polymorphism
in the 5’-flanking region of the NLRP3 gene, we further
hypothesized that the G ® A variation of the rs2027432
polymorphism might affect the promoter activities of
the NLRP3 gene. Figure 3 shows that the fold increase
of RLA was significantly higher in cells transfected with
the variant A allele than in those transfected with wild-
type G allele in the presence of LPS stimulation (1.72 vs
1.25; P = 0.03), whereas there was no statistical signifi-
cance between the two groups in the absence of LPS sti-
mulation (1.07 vs 1.09; P = 0.807).
Discussion
In the present study, to the best of our knowledge, we are
the first investigators to identify the potential clinical
relevance of the rs2027432, rs3738448, rs12048215,
Table 2 Overall clinical characteristics of patients with
major trauma
Clinical characteristics Patient data (N = 718)
Mean age ± SD (years) 40.6 ± 13.8
Age range (years) 18 to 65
Males/females, n 577/141
Mean ISS ± SD 22.5 ± 10.0
≥ 16 to < 25, n 413
≥ 25, n 305
Injured body regions, n
Head 385
Thorax 424
Abdomen 249
Extremities 431
Number of regions injured, n
Two 306
Three 177
All four 37
Organ dysfunction, n (%) 299 (41.6%)
One, n 215
Two, n 57
Three or above, n 27
Sepsis, n (%) 287 (40.0%)
Source of infection (%)
Respiratory tract infection 42.5
Primary bloodstream infection 20.2
Urinary tract infection 18.3
Catheter-associated infection 9.8
Wound infection 7.1
Others* 2.1
Pathogens (positive blood cultures) (%)
Gram-negative 17.1
Gram-positive 6.3
Fungi 8.7
Mixed Gram-negative and Gram-positive 11.1
Negative blood cultures 56.8
*Other sites of infection included soft-tissue infection, bone infection and ear
infection. ISS = Injury Severity Score.
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which are identified as tSNPs of the entire NLRP3 gene
in the Han Chinese population. tSNPs are a subset of all
variants within a chromosome region within a disease
study. The genetic effect of SNPs that are not genotyped
in the study can be detected through LD with a tSNP
[32]. In this case, the six tSNPs selected in the current
study theoretically reflect the biological significance of all
the genetic variations across the entire NLRP3 gene
because of their strong LD with other unassayed variants.
A case-control study is a common and convenient
association study design for finding a genetic basis of
disease. However, a major limitation of this approach is
the potential for population stratification when inap-
propriate patient-control matching occurs, such as using
healthy blood donors as the control group in the study.
To avoid confounding associations, we selected only
trauma patients and followed them prospectively to
determine whether those who had genetic variants had a
lesser or higher risk of posttraumatic MODS and sepsis.
In addition, we limited the patients recruited into this
study cohort to Han Chinese to avoid an artefact due to
population admixture. In the context of a biologically
relevant phenotype and a racially uniform population,
this might maximize the likelihood of finding a mean-
ingful genetic association. As shown by our clinical
association study, among the six tSNPs selected in our
study cohort, only two of them (rs2027432 and
rs12048215) had clinical relevance in relation to the
development of sepsis and MODS in trauma patients.
The rs2027432 polymorphism reveals higher risk with
the development of sepsis and MODS, in which there is
a significant association with MODS. The lack of a sta-
tistically significant association with sepsis might be due
to the very small number of patients with the AA geno-
type (n = 3), which is not quite enough for c
2 analysis.
For the rs12048215 polymorphism, the number of
patients appears to be big enough for each genotype
group (n = 398 for AA, n = 267 for AG and n =5 3f o r
G G ) .I th a sas i g n i f i c a n ta s s o ciation with lower risk of
sepsis and only a trend association with MODS. It sug-
gests that the rs2027432 polymorphism has stronger
clinical relevance than rs12048215. In addition,
rs2027432 and rs12048215 did not have a combined
effect in relation to risk of development of sepsis and
MODS, with no significant differences in sepsis morbid-
ity rate and MOD scores observed between trauma
patients with combined and single-variant genotypes
(AA-AA + GA-AA + GA-AG vs GG-AA + GG-AG).
The rs1539019, rs4612666C and rs10754558 polymorph-
isms, although well associated with heart disease [33],
food-induced anaphylaxis and aspirin-induced asthma
Table 3 Clinical relevance of the NLRP3 gene polymorphisms in patients with major trauma
Polymorphic sites Genotypes Number of patients Mean age ± SD
(years)
Sex
(M/F)
Mean ISS ± SD Sepsis, n (%) Mean MOD score ± SEM
GG 642 40.6 ± 13.8 513/129 22.5 ± 10.0 252 (39.3) 4.2 ± 0.1
rs2027432 GA 73 40.9 ± 12.9 60/13 22.4 ± 9.8 32 (43.8) 4.1 ± 0.4
AA 3 49.0 ± 26.1 3/0 21.7 ± 10.3 2 (66.7) 8.7 ± 1.2
P-value a1
GG 454 40.5 ± 13.5 369/85 22.2 ± 9.9 173 (38.1) 4.0 ± 0.2
rs3738448 GT 231 40.9 ± 14.4 176/55 22.9 ± 10.2 95 (41.1) 4.3 ± 0.2
TT 20 40.7 ± 13.3 18/2 22.4 ± 10.0 11 (55) 4.4 ± 0.8
AA 398 40.2 ± 13.8 320/78 22.3 ± 9.8 175 (44.0) 4.3 ± 0.2
rs12048215 AG 267 40.5 ± 13.6 217/50 22.9 ± 10.5 97 (36.3) 4.1 ± 0.2
GG 53 44.7 ± 14.1 39/14 21.4 ± 8.0 14 (26.4) 3.7 ± 0.1
P-value a2, b1
CC 193 39.6 ± 13.8 165/28 21.7 ± 9.3 76 (39.4) 4.0 ± 0.2
rs4612666 CT 380 40.6 ± 13.4 295/85 22.9 ± 10.6 156 (41.1) 4.2 ± 0.2
TT 138 42.4 ± 14.7 109/29 22.4 ± 9.2 49 (35.5) 4.0 ± 0.3
CC 251 40.1 ± 14.1 195/56 22.4 ± 9.4 111 (44.2) 4.2 ± 0.2
rs1539019 CA 349 40.4 ± 13.7 283/66 23.1 ± 10.1 129 (37.0) 4.3 ± 0.2
AA 118 40.0 ± 13.0 98/20 20.9 ± 10.5 46 (39.0) 3.9 ± 0.3
CC 246 40.5 ± 14.9 186/60 21.6 ± 9.1 99 (40.2) 3.9 ± 0.2
rs10754558 CG 354 40.6 ± 13.2 291/62 23.0 ± 10.3 134 (37.9) 4.4 ± 0.2
GG 114 40.3 ± 12.5 96/18 22.6 ± 10.7 51 (44.7) 3.9 ± 0.3
ISS = Injury Severity Score; MOD score = Multiple Organ Dysfunction score. a = recessive effect (variant homozygotes versus heterozygotes + wild-type
homozygotes); b = dominant effect (variant homozygotes + heterozygotes versus wild-type homozygotes) as analyzed by one-way analysis of variance. a1, P =
0.024; a2, P = 0.038; b1, P = 0.012.
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respectively, showed negative results in our study
cohort. Different ethnic populations and diseases might
account for these opposite results.
Given the clinical relevance of both the rs2027432 and
rs12048215 polymorphisms, we further hypothesized that
both genetic variations might be associated with IL-1b
production in patients with major trauma. The peripheral
blood was taken immediately after admission in an
attempt to avoid the potential effects of infection and fluid
resuscitation. Our results reveal that the two polymorph-
isms could affect the capacity of peripheral leukocytes to
produce IL-1b, showing significant association with higher
(rs2027432) and lower (rs12048215) IL-1b production,
respectively. But these two polymorphisms do not have a
combined effect on IL-1b production. This is in accor-
dance with their clinical relevance. rs12048215 is located
in the intron of the NLRP3 gene. Unfortunately, it is
unclear how a genetic variant in an intron affects the func-
tion of the gene. The effect of the rs12048215 on IL-1b
production might be due to other, unidentified causal
SNPs, which is in close LD with the rs12048215. The
rs2027432 polymorphism is located in the 5’-flanking
region of the NLRP3 gene, causing G-to-A variation at
position -1,017. To further determine whether the associa-
tion of the rs2027432 polymorphism with IL-1b
production is due to the direct effect of this polymorph-
ism, we further investigated the effect of the rs2027432
polymorphism on NLRP3 promoter activity using a repor-
ter gene assay system. Our results indicate that the G ® A
variation at position -1,017 could significantly enhance the
transcriptional activity of the NLRP3 promoter, leading to
increased expression of the NLRP3 gene. Results from
bioinformatics analysis further indicate that the mechan-
ism of the rs2027432 polymorphism’s affecting promoter
activity might be due to its effect on the binding of tran-
scription factor MyoD, which might be further confirmed
by a electrophoretic mobility shift assay. NLRP3 has been
recognized as a central molecule in the maturation and
secretion of IL-1b [31]. The rs2027432 polymorphism
might enhance IL-1b production through upregulation of
the expression of the NLRP3 gene.
Conclusions
In the present study, we investigated the clinical rele-
vance of the genetic variations within the entire NLRP3
gene by means of constructing haplotype bins in
patients with major trauma. We have demonstrated that
the rs2027432 and rs12048215 polymorphisms affect IL-
1b production and might be used to estimate risk for
sepsis and MODS in trauma patients. Further studies,
both clinical and experimental, are therefore needed to
confirm the significance of these findings and to investi-
gate their synergistic effect with other genetic poly-
morphisms in relation to the development of sepsis in
and the outcomes of trauma patients.
Figure 3 Effect of the rs2027432 polymorphism on the
transcription activity of the NLRP3 promoter. Relative luciferase
activity (RLA) was measured in human U937 cells transfected with
rs2027432G or rs2027432A plasmid constructs as described in
Methods. Luciferase activity was normalized for transfection
efficiency by using a control plasmid, pRL-CMV. The results are
expressed as fold increases in RLA of the NLRP3 promoter construct
vector as compared with pGL3-Basic (means ± SD). LPS =
lipopolysaccharide.
Figure 2 Effect of the rs2027432 and rs12048215
polymorphisms of the NLRP3 gene on IL-1b production. The
whole-blood samples collected from trauma patients immediately
after admission were mixed at a 1:1 ratio (vol/vol) with RPMI 1640
culture medium and incubated with 100 ng/ml bacterial
lipopolysaccharide at 37°C for 4 hours. The levels of IL-1b in the
supernatants were assayed by performing a sandwich ELISA. The
data are presented as means ± SD. One-way analysis of covariance
(ANCOVA) was used to assess statistical significance. *Dominant
effect (variant homozygotes + heterozygotes vs wild homozygotes)
assessed by ANCOVA: *
1P = 0.003, *
2P = 0.018.
#Recessive effect
(variant homozygotes vs heterozygotes + wild-type homozygotes)
assessed by ANCOVA:
#1P < 0.0001,
#2P = 0.00016.
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￿ The rs2027432A and rs12048215A alleles were sig-
nificantly associated with higher IL-1b production in
response to ex vivo LPS stimulation.
￿ The rs2027432 and rs12048215 polymorphisms
were closely associated with the development of sep-
sis and MODS.
￿ There are no marked synergistic effects among the
rs2027432 and rs12048215 polymorphisms in rela-
tion to the development of sepsis and MODS in
trauma patients.
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